fda tirzepatide injection shortage resolved october 2 2024 says the weight-loss drug is over Is the GLP-1 compounding boom

The establishment of an MDL would signify the judiciarys recognition of the substantial number of claims and the complexity of issues surrounding GLP-1 and vision loss

Cells , 13 (22), 1864

2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes

While it is not known if the impact on blood pressure was due to the medication or the participants weight loss, the lower blood pressure measures seen with tirzepatide rivalled what is seen for many hypertension medications. Tirzepatide works by mimicking two metabolic hormones in the body: it acts as a glucagon-like peptide-1 (GLP-1) receptor agonist and also as a glucose dependent insulinotropic polypeptide (GIP) receptor agonist